These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30952940)

  • 1. Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
    Saito H; Tanaka T; Sugahara M; Tanaka S; Fukui K; Wakashima T; Nangaku M
    Lab Invest; 2019 Jul; 99(8):1217-1232. PubMed ID: 30952940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.
    Uchida L; Tanaka T; Saito H; Sugahara M; Wakashima T; Fukui K; Nangaku M
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F388-F401. PubMed ID: 31841388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
    Sugahara M; Tanaka S; Tanaka T; Saito H; Ishimoto Y; Wakashima T; Ueda M; Fukui K; Shimizu A; Inagi R; Yamauchi T; Kadowaki T; Nangaku M
    J Am Soc Nephrol; 2020 Mar; 31(3):560-577. PubMed ID: 31996409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTZ-951, an HIF prolyl hydroxylase inhibitor, suppresses renal interstitial fibroblast transformation and expression of fibrosis-related factors.
    Wakashima T; Tanaka T; Fukui K; Komoda Y; Shinozaki Y; Kobayashi H; Matsuo A; Nangaku M
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F14-F24. PubMed ID: 31630548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
    Shinozaki Y; Fukui K; Kobayashi H; Yoshiuchi H; Matsuo A; Matsushita M
    Eur J Pharmacol; 2021 May; 898():173990. PubMed ID: 33657422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cobalt and mercury on lipid metabolism in the white adipose tissue of high-fat diet-induced obesity mice.
    Kawakami T; Hanao N; Nishiyama K; Kadota Y; Inoue M; Sato M; Suzuki S
    Toxicol Appl Pharmacol; 2012 Jan; 258(1):32-42. PubMed ID: 22019852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Ma Y; Gao M; Liu D
    Pharm Res; 2015 Apr; 32(4):1200-9. PubMed ID: 25248334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octacosanol and policosanol prevent high-fat diet-induced obesity and metabolic disorders by activating brown adipose tissue and improving liver metabolism.
    Sharma R; Matsuzaka T; Kaushik MK; Sugasawa T; Ohno H; Wang Y; Motomura K; Shimura T; Okajima Y; Mizunoe Y; Ma Y; Saber ZM; Iwasaki H; Yatoh S; Suzuki H; Aita Y; Han SI; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Shimano H
    Sci Rep; 2019 Mar; 9(1):5169. PubMed ID: 30914769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.
    Ferrari A; Fiorino E; Longo R; Barilla S; Mitro N; Cermenati G; Giudici M; Caruso D; Mai A; Guerrini U; De Fabiani E; Crestani M
    Int J Obes (Lond); 2017 Feb; 41(2):289-298. PubMed ID: 27795551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
    Börgeson E; Wallenius V; Syed GH; Darshi M; Lantero Rodriguez J; Biörserud C; Ragnmark Ek M; Björklund P; Quiding-Järbrink M; Fändriks L; Godson C; Sharma K
    Diabetologia; 2017 Apr; 60(4):729-739. PubMed ID: 28188334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Dietary Supplementation with Yerba Mate Ameliorates Diet-Induced Obesity and Metabolic Disorders in Mice by Regulating Energy Expenditure and Lipid Metabolism.
    Choi MS; Park HJ; Kim SR; Kim DY; Jung UJ
    J Med Food; 2017 Dec; 20(12):1168-1175. PubMed ID: 28872427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
    Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
    Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M.
    Poblete JMS; Ballinger MN; Bao S; Alghothani M; Nevado JB; Eubank TD; Christman JW; Magalang UJ
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E689-E700. PubMed ID: 32154744
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ahn H; Go GW
    J Microbiol Biotechnol; 2017 Apr; 27(4):660-667. PubMed ID: 28081360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice.
    Kaelin BR; McKenzie CM; Hempel KW; Lang AL; Arteel GE; Beier JI
    Toxicol Appl Pharmacol; 2020 Jul; 399():115068. PubMed ID: 32445754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
    Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
    PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.